Tuberculosis Therapy
Direct observation of treatment at health centers may be counterproductive
Published in Medical Letter on the CDC and FDA, June 9th, 2002
Dr. Muhammad Amir Khan and colleagues at the Association for Social Development and the United States Agency for International Development (USAID) office in Islamabad and the Universities of Leeds and York in the United Kingom conducted an study to "establish the costs and effectiveness of different strategies for implementing directly observed treatment (DOT) for tuberculosis."
Directly observed therapy...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Asthma
CDC reports asthma still a problem for millions - Pediatrics
Children greatest victims of degrading environment - Health Education
Foundation presses Capitol Hill on health education in elementary school - Streptococcus Pneumoniae
CDC assesses susceptibility testing practices in U.S. - AIDS Therapy
Drug warning issued by Glaxo - Contraception
Few know about pill for emergencies - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
